Background And Purpose: Laparoscopic pyeloplasty (LP) is a minimally invasive technique with high success rates that match open procedures. There are a variety of success definitions. We have defined and reported our success rate by objective renal scintigraphic criteria. We also compare our scintigraphic success with clinical success defined by absence of pain.

Patients And Methods: We reviewed retrospectively 111 adult cases of laparoscopic pyeloplasties. The Anderson-Hynes technique was used in 98% of cases. nonprimary pyeloplasties represented 12 cases of our series. Renal scintigraphic success rates were defined as: strict (T(1/2) <10 min), nonobstructive (T(1/2) <20 min), and technical success (improved T(1/2)). Of our patients, 83% had renal scintigraphy before and after surgery.

Results: Average operative time was 128 +/- 45 minutes, blood loss was 52 +/- 168 mL, and median postoperative hospital stay was 3 days. After surgery, T(1/2) was decreased by 26 minutes for a median time of 13 minutes. Strict success was achieved in 61% of cases, while nonobstructive success and technical success were achieved in 86% and 93%, respectively. No difference in success was observed between primary and nonprimary cases. Clinical success (absence of symptoms) was achieved in 95% of LPs. We also show that 75% of patients who had obstruction after LP based on scintigraphic criteria were asymptomatic, showing a poor correlation between symptoms and obstruction.

Conclusions: By defining success with renal scintigraphic criteria, we still obtain a high success rate. When using strict criteria, however, the success decreases and might identify patients at risk of late recurrence.

Download full-text PDF

Source
http://dx.doi.org/10.1089/end.2009.0134DOI Listing

Publication Analysis

Top Keywords

scintigraphic criteria
8
laparoscopic pyeloplasty
8
success rates
8
renal scintigraphic
8
scintigraphic success
8
success
6
determination success
4
success objective
4
scintigraphic
4
objective scintigraphic
4

Similar Publications

Validated approaches at mayo clinic for measuring gastric and colonic transit of solids and gastric accommodation.

Expert Rev Gastroenterol Hepatol

November 2024

Clinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R.), Division of Gastroenterology and Hepatology; Division of Nuclear Medicine, Department of Radiology Mayo Clinic, Rochester, MN, USA.

Introduction: Advancements in scintigraphic gastrointestinal motility testing that were developed, validated, and replicated in clinical practice at Mayo Clinic have significantly enhanced our understanding and management of gastrointestinal motility disorders. Importantly, normative values in at least 100 healthy controls and estimated inter- and intra-individual coefficient of variation for all parameters have been published for these tests.

Areas Covered: This article reviews methodology, accuracy, reproducibility, and diagnostic cutoffs of scintigraphic techniques for measuring gastric emptying, gastric accommodation, and colonic transit, comparing methods from Mayo Clinic with those used elsewhere when appropriate.

View Article and Find Full Text PDF

Post-infarction heart failure with reduced ejection fraction (HFrEF) patients often face persistent risks of sudden cardiac arrest leading to sudden cardiac death. While implanting a cardioverter-defibrillator (ICD) can enhance prognosis, complications and costs limit its widespread use. Current patient qualification criteria, relying on imperfect parameters, require refinement.

View Article and Find Full Text PDF

Additional criteria on scintigraphic testing for diagnosis of rapid colonic transit in patients with chronic diarrhea.

Neurogastroenterol Motil

November 2024

Clinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R.), Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.

Background: Colonic transit (CT) measured by validated scintigraphy using In-labeled activated charcoal particles is summarized using geometric center (GC) of isotopic distribution in four colonic regions and stool at 24 and 48 h. Diagnosis of rapid CT is currently based on GC24 ≥4.4 in females and >4.

View Article and Find Full Text PDF

Objectives: There is currently no reference standard test for the detection of the extra-esophageal manifestations of gastroesophageal reflux disease (GERD). The current suite of diagnostic tests principally assesses reflux events in the esophagus. A new scintigraphic technique has been developed and validated against reference standards.

View Article and Find Full Text PDF

Initial imaging evaluation of hydronephrosis of unknown etiology is a complex subject and is dependent on clinical context. In asymptomatic patients, it is often best conducted via CT urography (CTU) without and with contrast, MR urography (MRU) without and with contrast, or scintigraphic evaluation with mercaptoacetyltriglycine (MAG3) imaging. For symptomatic patients, CTU without and with contrast, MRU without and with contrast, MAG3 scintigraphy, or ultrasound of the kidneys and bladder with Doppler imaging are all viable initial imaging studies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!